Please assess the completion status of the following clinical trial:

Trial Title: Preoperative Viscous Lidocaine for Upper Gastrointestinal Endoscopy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients referred to and found fit for upper GI endoscopy in an out patient setting~* Between 18 and 75 years old~* Speaks and understands Danish~Exclusion Criteria:~* Patients admitted for upper GI endoscopy in an in-patient setting~* Patients with dementia and/or other cognitive dysfunction disorders~* Patients primarily complaining of dysphagia~* Patients allergic to lidocaine~* Patients with suspected retention~* Patients who will undergo upper GI endoscopy with nurse-assisted propofol sedation~* Patients who will undergo upper GI endoscopy with assistance of anesthesia-personnel

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Viscous lidocaine (Type: EXPERIMENTAL): Oral viscous lidocaine 20 mg/ml, 10 ml
- Placebo (Type: PLACEBO_COMPARATOR): Oral viscous solution without active drug, 10 ml

Based on this trial design, predict the completion outcome and termination type (if applicable).